|
FY2021
12 months to Jan 30, 2021
|
FY2020
12 months to Feb 1, 2020
|
FY2019
12 months to Feb 2, 2019
|
FY2018
12 months to Feb 3, 2018
|
FY2017
12 months to Jan 28, 2017
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Amortization of acquired intangible assets | |||||
| Amortization of inventory fair value adjustment associated with acquisitions | |||||
| Amortization of deferred debt issuance costs and debt discounts | |||||
| Restructuring related impairment charges (gain) | |||||
| Amortization of premium /discount on available-for-sale securities | |||||
| Excess tax benefits from share-based compensation | |||||
| Deferred income taxes | |||||
| Gain on sale of discontinued operations | |||||
| Loss (gain) on sale of business | |||||
| Other expense, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities and other non-current liabilities | |||||
| Carnegie Mellon University accrued litigation settlement | |||||
| Accrued employee compensation | |||||
| Deferred income | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of available-for-sale securities | |||||
| Sales of available-for-sale securities | |||||
| Maturities of available-for-sale securities | |||||
| Purchases of time deposits | |||||
| Maturities of time deposits | |||||
| Purchases of technology licenses | |||||
| Purchases of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Cash payment for acquisitions, net of cash and cash equivalents acquired | |||||
| Net proceeds from sale of discontinued operations | |||||
| Net proceeds from sale of business | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repurchases of common stock | |||||
| Proceeds from employee stock plans | |||||
| Tax withholding paid on behalf of employees for net share settlement | |||||
| Dividend payments to shareholders | |||||
| Payments on technology license obligations | |||||
| Excess tax benefits from share-based compensation | |||||
| Proceeds from issuance of debt | |||||
| Principal payments of debt | |||||
| Payment of equity and debt financing costs | |||||
| Other, net | |||||
| Net cash provided by (used in) in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
Loading...